Reuters logo
BRIEF-Immupharma ‍says FY diluted loss per share was 4.54 pence
June 1, 2017 / 6:29 AM / 6 months ago

BRIEF-Immupharma ‍says FY diluted loss per share was 4.54 pence

June 1 (Reuters) - Immupharma Plc:

* Top line results anticipated in Q1 2018​

* FY loss for period of £5.3 million

* ‍No dividend is proposed​

* FY basic and diluted loss per share was 4.54p​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below